Literature DB >> 9288674

Differential effects of endothelin-1 on basal and isoprenaline-enhanced Ca2+ current in guinea-pig ventricular myocytes.

G P Thomas1, S M Sims, M Karmazyn.   

Abstract

1. We examined the effect of endothelin-1 (ET-1) on basal and isoprenaline-enhanced L-type Ca2+ current (ICa,L) in guinea-pig ventricular myocytes under nystatin-perforated patch configuration. 2. ET-1 at concentrations of 1, 5 and 10 nM had little effect on basal ICa,L. However, ICa,L enhanced by isoprenaline (500 nM) was significantly attenuated by 5 nM ET-1 by more than 50%. This effect was reversed upon washout. ICa,L enhanced by forskolin was also decreased by ET-1. 3. The inhibitory effect of ET-1 against isoprenaline was completely blocked by the ETA receptor antagonist BQ-123 (1 microM). In myocytes incubated with pertussis toxin (PTX, 2 micrograms ml-1) for 5 h, ET-1 did not inhibit isoprenaline-enhanced ICa,L. 4. Although ET-1 has been shown to activate specific protein kinase C (PKC) isoforms, a significant inhibitory effect of ET-1 was maintained in the presence of the PKC inhibitor bisindolylmaleimide (20 nM). The nitric oxide (NO) donor SIN-1 (10 microM) attenuated but failed to prevent the ET-1 effect. 5. In summary, our results demonstrate that ET-1 is devoid of any significant effects on basal ICa,L. However, it exerts a potent inhibitory effect against isoprenaline-enhanced ICa,L. This effect is mediated through ETA receptors coupled to PTX-sensitive G-proteins and occurs in the presence of PKC inhibition and NO generation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9288674      PMCID: PMC1159886          DOI: 10.1111/j.1469-7793.1997.055bi.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  35 in total

Review 1.  The role of endothelins in cardiac function in health and disease.

Authors:  M Karmazyn
Journal:  EXS       Date:  1996

2.  Modulation of endothelin-1 effects on rat hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.

Authors:  Y Ebihara; J V Haist; M Karmazyn
Journal:  J Mol Cell Cardiol       Date:  1996-02       Impact factor: 5.000

3.  Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes.

Authors:  M Pucéat; R Hilal-Dandan; B Strulovici; L L Brunton; J H Brown
Journal:  J Biol Chem       Date:  1994-06-17       Impact factor: 5.157

4.  ET-1 stimulates Ca2+ currents in cardiac cells.

Authors:  G Bkaily; S Wang; M Bui; D Ménard
Journal:  J Cardiovasc Pharmacol       Date:  1995       Impact factor: 3.105

Review 5.  Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.

Authors:  G M Rubanyi; M A Polokoff
Journal:  Pharmacol Rev       Date:  1994-09       Impact factor: 25.468

6.  Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents.

Authors:  K Ono; G Tsujimoto; A Sakamoto; K Eto; T Masaki; Y Ozaki; M Satake
Journal:  Nature       Date:  1994-07-28       Impact factor: 49.962

7.  Endothelin-1 inhibits L-type Ca currents enhanced by isoproterenol in guinea-pig ventricular myocytes.

Authors:  L H Xie; M Horie; A F James; M Watanuki; S Sasayama
Journal:  Pflugers Arch       Date:  1996-02       Impact factor: 3.657

8.  An obligatory role for nitric oxide in autonomic control of mammalian heart rate.

Authors:  X Han; Y Shimoni; W R Giles
Journal:  J Physiol       Date:  1994-04-15       Impact factor: 5.182

9.  Endothelin ETA-receptors couple to inositol phosphate formation and inhibition of adenylate cyclase in human right atrium.

Authors:  M Vogelsang; A Broede-Sitz; E Schäfer; H R Zerkowski; O E Brodde
Journal:  J Cardiovasc Pharmacol       Date:  1994-02       Impact factor: 3.105

10.  Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase.

Authors:  G M Wahler; S J Dollinger
Journal:  Am J Physiol       Date:  1995-01
View more
  7 in total

1.  Endothelin-1 and photoreleased diacylglycerol increase L-type Ca2+ current by activation of protein kinase C in rat ventricular myocytes.

Authors:  J Q He; Y Pi; J W Walker; T J Kamp
Journal:  J Physiol       Date:  2000-05-01       Impact factor: 5.182

2.  The antifungal antibiotic clotrimazole potently inhibits L-type calcium current in guinea-pig ventricular myocytes.

Authors:  G P Thomas; M Karmazyn; A C Zygmunt; C Antzelevitch; N Narayanan
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

Review 3.  The cardiovascular physiology and pharmacology of endothelin-1.

Authors:  Eric Thorin; Martine Clozel
Journal:  Adv Pharmacol       Date:  2010

4.  Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthase.

Authors:  Gerald Wölkart; Heike Stessel; Zora Saad; Michael Kirchengast; Friedrich Brunner
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

5.  G protein-mediated inhibitory effect of a nitric oxide donor on the L-type Ca2+ current in rat ventricular myocytes.

Authors:  N Abi-Gerges; R Fischmeister; P F Méry
Journal:  J Physiol       Date:  2001-02-15       Impact factor: 5.182

6.  Protein kinase C isoforms differentially phosphorylate Ca(v)1.2 alpha(1c).

Authors:  Lin Yang; Darshan Doshi; John Morrow; Alexander Katchman; Xiang Chen; Steven O Marx
Journal:  Biochemistry       Date:  2009-07-21       Impact factor: 3.162

7.  Improvement in cardiac function of diabetic rats by bosentan is not associated with changes in the activation of PKC isoforms.

Authors:  Jihong Jiang; Violet Yuen; Hong Xiang; John H McNeill
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.842

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.